US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 102.710
  • -0.920-0.89%
Close May 22 16:00 ET
  • 103.000
  • +0.290+0.28%
Pre 06:57 ET
6.43BMarket Cap-21309P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Blueprint Medicines Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

96.12M

+51.87%
EPS(YoY)

1.40

+165.12%
Analyst Rating

Buy

May 16, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 111.931M--
--2024/Q2-- / 102.698M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
Aug 2, 20232023/Q257.570M / 45.603M--
May 4, 20232023/Q163.287M / 41.853M--
Feb 16, 20232022/Q438.781M / 33.521M--
--2022/Q365.977M / 43.876M--
Aug 2, 20222022/Q236.547M / 37.613M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 111.931M--
--2024/Q2-- / 102.698M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
Aug 2, 20232023/Q257.570M / 45.603M--
May 4, 20232023/Q163.287M / 41.853M--
Feb 16, 20232022/Q438.781M / 33.521M--
--2022/Q365.977M / 43.876M--
Aug 2, 20222022/Q236.547M / 37.613M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

  • Blueprint Medicines | 10-Q: Quarterly report

    May 2 16:51 ET

  • Blueprint Medicines | 10-K: Annual report

    Feb 15 22:20 ET

  • Blueprint Medicines | 10-Q: Q3 2023 Earnings Report

    Oct 26, 2023 16:01 ET

  • Blueprint Medicines | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 16, 2024

    Buy

    • Buy

      66.67%

    • Hold

      26.67%

    • Sell

      6.67%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Cancer Research
    Cancer Research
    Intraday+0.58%